Non-invasive biomarkers FibroTest-ActiTest for replacing invasive liver biopsy: the need for change and action.
نویسنده
چکیده
J Gastrointestin Liver Dis June 2007 Vol.16 No 2, 173-174 Address for correspondence: 1 Bedossa et al. found the best diagnostic value for discriminating between F0-F1 and F2-F4 METAVIR that can be obtained for the liver biopsy versus the entire liver is 0.90 AUROC for a 20mm nonfragmented liver biopsy. 2 Regev et al. suggested that an adequate non fragmented liver biopsy sample contain more than five portal tracts and be at least 15mm in length. 3 DANA= Differences between Advanced and Non-Advanced fibrosis stages. Non-invasive Biomarkers FibroTest-ActiTest for Replacing Invasive Liver Biopsy: The need for Change and Action
منابع مشابه
Liver biopsy versus noninvasive methods--fibroscan and fibrotest in the diagnosis of non-alcoholic fatty liver disease: a review of the literature.
The prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing in general population so it is impossible to perform liver biopsy in such a large number of patients to identify those with advanced fibrosis or non-alcoholic steatohepatitis. Liver biopsy has a potential sampling error, it is invasive and prone to complications, so it is no longer considered as mandatory as first line sc...
متن کاملPerformance of Biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in Patients with Severe Obesity: Meta Analysis of Individual Patient Data
BACKGROUND Liver biopsy is considered as the gold standard for assessing non-alcoholic fatty liver disease (NAFLD) histologic lesions in patients with severe obesity. The aim of this study was to perform an overview of 3 studies which assessed the performance of non-invasive markers of fibrosis (FibroTest), steatosis (SteatoTest) and steato-hepatitis (NashTest, ActiTest) in these patients. ME...
متن کاملFibroTest/FibroSure Scientific Publications
1162 NAFLD Diagnostic performance of FibroTest, SteatoTest, and ActiTest in patients with NAFLD using the SAF-score as histological reference M Munteanu, D Tiniakos, Q Anstee, F Charlotte, G Marchesini, E Bugianesi, MH. Trauner, CP. Oliveira, C Day, JF Dufour, S Bellentani, Y Ngo, S Traussnigg, P Bedossa, V Ratziu, T Poynard. The study aimed to improve the validation of three blood tests used i...
متن کاملNoninvasive biomarkers FibroTest and ActiTest versus liver biopsy in chronic hepatitis C patients: the Middle East experience
BACKGROUND The aim of this study was to compare noninvasive biomarkers, FibroTest and ActiTest in predicting fibrosis stage and inflammation grade in chronic hepatitis C (CHC) patients with liver biopsy (LB). METHODS In 107 patients with CHC, levels of six serum biomarkers (alanine aminotransferase, γ-glutamyl transpeptidase, total bilirubin, haptoglobin, apolipoprotein, α-2 macroglobulin) we...
متن کاملValidation of noninvasive biomarkers (FibroTest, SteatoTest, and NashTest) for prediction of liver injury in patients with morbid obesity.
BACKGROUND Liver biopsy is considered as the gold standard for assessing nonalcoholic fatty liver disease (NAFLD) histologic lesions in patients with morbid obesity. The aim of this study was to determine the diagnostic utility of noninvasive markers of fibrosis (FibroTest), steatosis (SteatoTest), and steatohepatitis (NashTest, ActiTest) in these patients. MATERIALS AND METHODS Two hundred a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Journal of gastrointestinal and liver diseases : JGLD
دوره 16 2 شماره
صفحات -
تاریخ انتشار 2007